Loading viewer...
earnings
Format: PDF earnings
Innovent Biologics' 2022 interim results presentation covering first-half business performance and financial position. The presentation includes forward-looking statements regarding the company's clinical development pipeline, business strategy, and operational objectives in the competitive biotech sector.
Innovent Biologics 2023 J.P. Morgan Healthcare Conference
conferenceconference
22 Pages
earnings
12 Pages
Unknown
Global Ship Lease Q2 2016 Earnings Results
earningsearnings
18 Pages
Global Ship Lease